Effects of Erythropoietin-Promoted Fracture Healing on Bone Turnover Markers in Cats
Source abstract
Abstract
In orthopaedics, erythropoietin (EPO) is applied in the preoperative management of anaemic patients, but also as a stimulating factor to assist bone regeneration due to its angiogenic and osteoinductive potential. Since orthopaedists mainly rely on their clinical experience to assess bone healing, additional and more objective methods such as studying the dynamics of bone markers are needed. Therefore, the aim of this study was to investigate the plasma activity of bone-specific alkaline phosphatase (BALP), the N-terminal propeptide of type I collagen (PINP), the C-terminal telopeptide of type I collagen (CTX), and deoxypyridinoline (DPD) during the first 2 months of healing of comminuted fractures in cats, either non-stimulated or locally stimulated with recombinant human erythropoietin (rhEPO). The study included twelve cats of mixed breeds, aged 7.2 ± 4 months, weighing 2.11 ± 1.1 kg, with comminuted diaphyseal fractures of the femur. Surgical treatment with plate osteosynthesis was performed in all animals. The cats were randomly divided into two groups—a control (n = 6) and an EPO group (n = 6). The locally applied EPO leads to the increased activity of bone formation markers (BALP and PINP) during the second week after the osteosynthesis, preceding the peaks in the control group by two weeks. The studied bone resorption markers (DPD, CTX) varied insignificantly during the studied period. In conclusion, erythropoietin could serve as a promoter of bone healing in comminuted fractures in cats.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Periodontal Regeneration and Treatments · Bone fractures and treatments · Tendon Structure and Treatment
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Veterinary Surgery, Faculty of Veterinary Medicine, Trakia University, 6000 Stara Zagora, Bulgaria
Department of Pharmacology, Animal Physiology, Biochemistry and Chemistry, Faculty of Veterinary Medicine, Trakia University, 6000 Stara Zagora, Bulgaria
Funding
Faculty of Veterinary Medicine, Trakia University, Stara Zagora, 6000, Bulgaria
References (79)
Show source-provided references
1. Suresh, S., Lee, J., and Noguchi, C.T. (2020). Effects of Erythropoietin in White Adipose Tissue and Bone Microenvironment. Front. Cell Dev. Biol., 8.10.3389/fcell.2020.584696 ↗
2. Erythropoietin (EPO): EPO-receptor signaling improves early endochondral ossification and mechanical strength in fracture healing10.1016/j.lfs.2006.11.023 ↗
3. Effects of Recombinant Human Erythropoietin on Mandibular Distraction Osteogenesis10.1016/j.joms.2008.06.082 ↗
4. Betsch, M., Thelen, S., Santak, L., Herten, M., Jungbluth, P., Miersch, D., Hakimi, M., and Wild, M. (2014). The role of erythropoietin and bone marrow concentrate in the treatment of osteochondral defects in mini-pigs. PLoS ONE, 9.10.1371/journal.pone.0092766 ↗
5. Erythropoietin augments bone formation in a rabbit posterolateral spinal fusion model10.1002/jor.22027 ↗
6. Shiozawa, Y., Jung, Y., Ziegler, A.M., Pedersen, E.A., Wang, J., Wang, Z., Song, J., Wang, J., Lee, C.H., and Sud, S. (2010). Erythropoietin couples hematopoiesis with bone formation. PLoS ONE, 5.10.1371/journal.pone.0010853 ↗
7. The efficacy of pre-operative preparation with intravenous iron and/or erythropoietin in anaemic patients undergoing orthopaedic surgery: An observational study10.1097/EJA.0000000000000752 ↗
8. Application and prospects of erythropoietin in bone tissue engineering
9. Pandya, M., Saxon, M., Bozanich, J., Tillberg, C., Luan, X., and Diekwisch, T. (2021). The Glycoprotein/Cytokine Erythropoietin Promotes Rapid Alveolar Ridge Regeneration In Vivo by Promoting New Bone Extracellular Matrix Deposition in Conjunction with Coupled Angiogenesis/Osteogenesis. Int. J. Mol. Sci., 22.10.3390/ijms22062788 ↗
10. Effects of erythropoietin on osteoblast in the tooth extraction socket in mice periodontitis model10.3389/fphys.2022.987625 ↗
11. A review on biomaterials-based scaffold: An emerging tool for bone tissue engineering10.1016/j.mtcomm.2022.105124 ↗
12. Ren, X., Zhao, M., Lash, B., Martino, M.M., and Julier, Z. (2020). Growth Factor Engineering Strategies for Regenerative Medicine Applications. Front. Bioeng. Biotechnol., 7.10.3389/fbioe.2019.00469 ↗
13. A single topical dose of erythropoietin applied on a collagen carrier enhances calvarial bone healing in pigs10.3109/17453674.2014.889981 ↗
14. Injectable hyaluronic acid microhydrogels for controlled release formulation of erythropoietin10.1002/jbm.a.30997 ↗
15. An injectable and thermosensitive hydrogel: Promoting periodontal regeneration by controlled-release of aspirin and erythropoietin10.1016/j.actbio.2019.01.001 ↗
16. Effects of systemic erythropoietin treatment and heterogeneous xenograft in combination on bone regeneration of a critical-size defect in an experimental model10.1016/j.jcms.2018.09.015 ↗
17. Three-dimensional TCP scaffolds enriched with Erythropoietin for stimulation of vascularization and bone formation10.29333/ejgm/108620 ↗
18. Vasileva, R., and Chaprazov, T. (2023). Bone Healing of Critical-Sized Femoral Defects in Rats Treated with Erythropoietin Alone or in Combination with Xenograft. Vet. Sci., 10.10.3390/vetsci10030196 ↗
19. Loading of erythropoietin on biphasic calcium phosphate bioceramics promotes osteogenesis and angiogenesis by regulating EphB4/EphrinB2 molecules10.1007/s10856-022-06644-9 ↗
20. Silk Fibroin/Collagen/Hydroxyapatite Scaffolds Obtained by 3D Printing Technology and Loaded with Recombinant Human Erythropoietin in the Reconstruction of Alveolar Bone Defects10.1021/acsbiomaterials.2c00690 ↗
21. Fu, Y., Cui, S., Luo, D., and Liu, Y. (2021). Novel Inorganic Nanomaterial-Based Therapy for Bone Tissue Regeneration. Nanomaterials, 11.10.3390/nano11030789 ↗
22. Shao, J., Nie, P., Yang, W., Guo, R., Ding, D., Liang, R., Wei, B., and Wei, H. (2022). An EPO-loaded multifunctional hydrogel synergizing with adipose-derived stem cells restores neurogenic erectile function via enhancing nerve regeneration and penile rehabilitation. Bioeng. Transl. Med., 7.10.1002/btm2.10319 ↗
23. Xue, N., Ding, X., Huang, R., Jiang, R., Huang, H., Pan, X., Min, W., Chen, J., Duan, J.A., and Liu, P. (2022). Bone Tissue Engineering in the Treatment of Bone Defects. Pharmaceuticals, 15.10.3390/ph15070879 ↗
24. Local erythropoietin injection in tibiofibular fracture healing10.5812/traumamon.7099 ↗
25. Aslroosta, H., Yaghobee, S., Akbari, S., and Kanounisabet, N. (2021). The effects of topical erythropoietin on non-surgical treatment of periodontitis: A preliminary study. BMC Oral. Health, 21.10.1186/s12903-021-01607-y ↗
26. A quantitative serum biomarker of circulating collagen X effectively correlates with endochondral fracture healing10.1002/jor.24776 ↗
27. Assessment of Bone Healing: Opportunities to Improve the Standard of Care10.2106/JBJS.22.01224 ↗
28. Clinical Utility of Biochemical Marker of Bone Turnover: Fracture Risk Prediction and Bone Healing10.11005/jbm.2018.25.2.73 ↗
29. Bone turnover markers for early detection of fracture healing disturbances: A review of the scientific literature10.1590/0001-3765201520150008 ↗
30. Serum alkaline phosphatase: A prospective biomarker for assessment of progress of fracture healing in diaphyseal fractures of long bones in adult patients10.22271/ortho.2020.v6.i2d.2047 ↗
31. Updates on Paget’s Disease of Bone10.3803/EnM.2022.1575 ↗
32. Williams, C., and Sapra, A. (2024). StatPearls, StatPearls Publishing.
33. Oncological validation of bone turnover markers c-terminal telopeptide of type I collagen (1CTP) and peptides n-terminal propeptide of type I procollagen (P1NP) in patients with prostate cancer and bone metastases10.21037/tau-20-1120 ↗
34. Modern markers for evaluating bone disease in multiple myeloma (Review)10.3892/etm.2021.10764 ↗
35. Heymann, D. (2022). Bone Sarcomas and Bone Metastases—From Bench to Bedside, Academic Press. [3rd ed.].
36. Serum soluble bone turnover biomarkers in psoriatic arthritis and psoriatic spondyloarthropathy10.3899/jrheum.140223 ↗
37. Janković, T., Mikov, M., Zvekić Svorcan, J., Minaković, I., Mikov, J., Bošković, K., and Mikić, D. (2023). Changes in Bone Metabolism in Patients with Rheumatoid Arthritis during Tumor Necrosis Factor Inhibitor Therapy. J. Clin. Med., 12.10.3390/jcm12051901 ↗
38. Bone Turnover Marker Profiling and Fracture Risk in Older Women: Fracture Risk from Age 75 to 9010.1007/s00223-022-00996-8 ↗
39. Bone turnover markers as surrogates of fracture healing after intramedullary fixation of tibia and femur fractures10.1302/2046-3758.114.BJR-2021-0226.R1 ↗
40. 10 Extra-label bisphosphonate effects on bone turnover biomarkers in juvenile, exercising horses10.1016/j.jevs.2023.104312 ↗
41. Clodronate detection and effects on markers of bone resorption are prolonged following a single administration to horses10.1111/evj.13866 ↗
42. Do serological tissue turnover markers represent callus formation during fracture healing?10.1016/j.bone.2005.06.008 ↗
43. Brankovič, J., Leskovec, J., Šturm, S., Cerkvenik-Flajs, V., Šterpin, S., Osredkar, J., Pogorevc, E., Antolinc, D., and Vrecl, M. (2022). Experimental Exposure to Bisphenol A Has Minimal Effects on Bone Tissue in Growing Rams—A Preliminary Study. Animals, 12.10.3390/ani12172179 ↗
44. Markers of bone metabolism in dog breeds of different sizes10.1016/S0034-5288(03)00110-3 ↗
45. Biochemical markers of bone turnover in the domestic cat: Relationships with age and feline osteoclastic resorptive lesions10.1093/jn/132.6.1742S ↗
46. A comparison of methods for measuring serum and urinary markers of bone metabolism in cats10.1016/j.rvsc.2004.02.007 ↗
47. Measurement of arthritic and bone serum metabolites in arthritic, noon-arthritic and geriatric cats fed wellness food
48. The influence of sex and age on bone turnover markers in the adult to geriatric Kangal shepherd dogs10.1111/vcp.13199 ↗
49. Does bone mobilization interfere with energy metabolism in transition cows?10.3168/jdsc.2022-0239 ↗
50. Comparative investigation on blood bone markers in normally healing and infected bone fracture models in dogs
51. The use of alkaline phosphatase and runx2 to distinguish osteosarcoma from other common malignant primary bone tumors in dogs10.1177/03009858221083035 ↗
52. Changes in some serum bone markers after experimental fracture and intramedullary osteosynthesis in dogs
53. Dhillon, M., Dha, S., and De Boer, P. (2012). First Aid and Emergency Management in Orthopedic Injuries, JP Medical Ltd.. [1st ed.].
54. Tsiftsoglou, A.S. (2021). Erythropoietin (EPO) as a Key Regulator of Erythropoiesis, Bone Remodeling and Endothelial Transdifferentiation of Multipotent Mesenchymal Stem Cells (MSCs): Implications in Regenerative Medicine. Cells, 10.10.3390/cells10082140 ↗
55. Gu, Z., Qiu, C., Chen, L., and Wang, X. (2024). Injectable thermosensitive hydrogel loading erythropoietin and FK506 alleviates gingival inflammation and promotes periodontal tissue regeneration. Front. Bioeng. Biotechnol., 11.10.3389/fbioe.2023.1323554 ↗
56. Sheen, J.R., Mabrouk, A., and Garla, V.V. (2024). StatPearls, StatPearls Publishing.
57. Plasma bone-specific alkaline phosphatase as an indicator of osteoblastic activity10.1302/0301-620X.75B2.8444951 ↗
58. Quantification and comparison of bone-specific alkaline phosphatase with two methods in normal and paget’s specimens
59. Variations of serum bone alkaline phosphatase activities and osteocalcin concentrations in dogs with experimental osteotomy fixed by two different osteosynthesis techniques
60. Parathyroid hormone, calcitonin and vitamin D metabolites during normal fracture healing in humans a preliminary report10.1097/00003086-198403000-00035 ↗
61. Assessment of union in fractures: Role of Serum Alkaline Phosphatase and Ultrasonography10.1016/j.jcot.2020.08.004 ↗
62. Erythropoietin promotes bone formation through EphrinB2/EphB4 signaling10.1177/0022034514566431 ↗
63. Erythropoietin mediated bone formation is regulated by mTOR signaling10.1002/jcb.23347 ↗
64. The osteogenic effect of erythropoietin on human mesenchymal stromal cells is dose-dependent and involves non-hematopoietic receptors and multiple intracellular signaling pathways10.1007/s12015-013-9476-x ↗
65. Erythropoietin inhibits osteoblast function in myelodysplastic syndromes via the canonical Wnt pathway10.3324/haematol.2017.172726 ↗
66. Erythropoietin does not improve fracture healing in aged mice10.1016/j.exger.2019.04.005 ↗
67. Recent advances in the use of serological bone formation markers to monitor callus development and fracture healing10.1615/CritRevEukarGeneExpr.v20.i2.20 ↗
68. Bone mineral density and bone markers in patients with a recent low-energy fracture: Effect of 1 y of treatment with calcium and vitamin D10.1093/ajcn/86.1.251 ↗
69. Effect of fracture on bone turnover markers: A longitudinal study comparing marker levels before and after injury in 113 elderly women10.1359/jbmr.070505 ↗
70. Bone Turnover Markers in the Diagnosis and Monitoring of Metabolic Bone Disease10.1373/clinchem.2016.259085 ↗
71. Kuo, T.R., and Chen, C.H. (2017). Bone biomarker for the clinical assessment of osteoporosis: Recent developments and future perspectives. Biomark. Res., 5.10.1186/s40364-017-0097-4 ↗
72. Macías, I., Alcorta-Sevillano, N., Rodríguez, C.I., and Infante, A. (2020). Osteoporosis and the Potential of Cell-Based Therapeutic Strategies. Int. J. Mol. Sci., 21.10.3390/ijms21051653 ↗
73. Alterations in serum tartrate-resistant acid phosphatase and C-terminal telopeptide of type I collagen in experimental canine osteotomies fixed using 2 different techniques
74. The efficacy of the bone markers osteocalcin and the carboxyterminal cross-linked telopeptide of type-I collagen in evaluating osteogenesis in a canine crural lengthening model10.1016/j.tvjl.2005.02.001 ↗
75. Erythropoietin directly stimulates osteoclast precursors and induces bone loss10.1096/fj.14-259085 ↗
76. Erythropoietin modulates bone marrow stromal cell differentiation10.1038/s41413-019-0060-0 ↗
77. Kolomansky, A., Hiram-Bab, S., Ben-Califa, N., Liron, T., Deshet-Unger, N., Mittelman, M., Oster, H.S., Rauner, M., Wielockx, B., and Neumann, D. (2020). Erythropoietin Mediated Bone Loss in Mice Is Dose-Dependent and Mostly Irreversible. Int. J. Mol. Sci., 21.10.3390/ijms21113817 ↗
78. Erythropoietin administration does not influence the GH–IGF axis or makers of bone turnover in recreational athletes10.1111/j.1365-2265.2005.02342.x ↗
79. Comparison in bone turnover markers during early healing of femoral neck fracture and trochanteric fracture in elderly patients